The Florida Orthopaedic Institute.

The twelve core clinical centers that Consortium Consortium Boston University Medical Center Boston University Medical Center, the Florida Orthopaedic Institute, Carolinas Medical Center, Denver Health and Hospital Authority, OrthoIndy and the Indiana Orthopaedic Hospital, Orthopaedic Associates of Michigan, The Orthopaedic Trauma Institute at the University of California San Francisco, San Francisco General Hospital, The University of Maryland Medical Center, R Adams Cowley Shock Trauma Center, The University of Mississippi Medical Center, The University of Texas Southwestern Medical Center, The University of Washington Harborview Medical Center and Vanderbilt University Medical Center..

The overall goal of the consortium is to provide multi-center clinical trials, surveys the worn for the treatment and outcome of severe orthopedic trauma on the battlefield. These studies will contribute. Treatment guidelines and support the implementation of new and emerging technologies into clinical practice ‘The need for such a consortium is evident,’said Ellen MacKenzie, These include thetigator and the Fred and Julie Soper Professor and Chair the Bloomberg School’s Department of Health Policy and Management. ‘Eighty – two % of all service members wounded upright in Operation Iraqi Freedom and Operation Enduring Freedom extremity trauma. Many consider injury of multiple limbs. Research Consortium will be conducted to help us better understand what works and what treat treat violations and to ensure that our service members possible with the best care are.About Multiple SclerosisMultiple sclerosis is an chronic inflammatory disease of the central nervous system and which most common, non – traumatic, disabling neurological disease in young adults. Multiple sclerosis there are approximately two million around the world. To symptoms can vary , the most common symptoms of multiple sclerosis vision, numbness or tingling the limbs and problems with strength and coordination. The relapsing forms of multiple sclerosis are the most frequent.

About SeronoSerono is a global leading biotechnology company. Company did eight biotechnology products, Rebif? Gonal-F? Luveris? Ovidrel? / Ovidrel? Serostim? Zorbtive? and Raptiva? are novel compounds which the world leader in reproductive health care, Serono has strong market positions in neurology, metabolism and growth and has recently the psoriasis area. That research programs are focused on growing these businesses and on establishing new therapeutic areas. Is currently around 30 projects in development.